Form 4: Nukkleus Director Yeganeh Receives 10,000 Shares

Nukkleus Inc. Director Reuven Yeganeh was granted 10,000 shares of common stock as compensation for services rendered.

Summary

• Reuven Yeganeh, a Director of Nukkleus Inc. (NUKK), acquired 10,000 shares of common stock.
• The transaction occurred on November 13, 2025.
• The shares were issued at a price of $0 as compensation for services rendered under the Company's 2025 Equity Incentive Plan.
• Following this transaction, Mr. Yeganeh directly beneficially owns 20,000 shares of Nukkleus Inc. common stock.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. The grant aligns director interests with shareholders, but it's a routine compensation event with no immediate significant impact on company operations or valuation beyond minor dilution.

Positives

• Director Reuven Yeganeh received 10,000 shares, indicating continued alignment of management interests with shareholders.
• The issuance is part of the company's 2025 Equity Incentive Plan, suggesting a structured approach to executive compensation and retention.

Negatives

• The shares were issued at a $0 price, which, while common for equity compensation, represents dilution for existing shareholders if not tied to performance milestones.

Future Outlook

NA

Industry Context

This is a routine insider transaction filing. It reflects standard practice for compensating directors with equity, aligning their interests with the company's long-term performance. It does not provide broader industry trends.

Comparison to Industry Standards

• Granting equity as compensation to directors is a common practice across industries, including financial technology and digital asset sectors, to incentivize long-term commitment and performance.
• The specific amount of 10,000 shares would need to be benchmarked against similar-sized companies and director compensation packages in the fintech space to assess its relative value, but this filing alone does not provide enough context for a detailed comparison.

Related Party Transactions

• The issuance of 10,000 shares to Director Reuven Yeganeh under the 2025 Equity Incentive Plan can be considered a related party transaction as it involves a company insider.

Stakeholder Impact

• Shareholders: Minor dilution from the issuance of new shares, but also potential benefit from increased director alignment with company performance.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Key Dates

Recommendation

This Form 4 filing reports a routine equity grant to a director as part of their compensation. While it aligns the director's interests with shareholders, it does not present new information that would fundamentally alter the investment thesis for Nukkleus Inc. Therefore, a 'hold' recommendation is appropriate, maintaining current positions based on broader company fundamentals rather than this specific transaction.

Keywords

Nukkleus Inc., NUKK, Reuven Yeganeh, Form 4, Insider Trading, Equity Compensation, Director Stock Grant, Beneficial Ownership, Stock Award